ClinicalTrials.gg
RecruitingNCT06484322SEE2:0Updated Sep 17, 2025

Strategies Empowering Activities in Everyday Life: An Internet-based Occupational Therapy Intervention

An interventional study of Strategies Empowering Activities in Everyday life (SEE 2.0) in Chronic Disease, sponsored by Luleå Tekniska Universitet. Recruiting at 2 sites in Sweden. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-09-17.

Sponsored by Luleå Tekniska Universitet · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of the study is to evaluate the feasibility, potential outcomes and the implementation process of a second updated version of an internet-based intervention in occupational therapy, focusing on self-management in activities of everyday life to promote health in people with chronic diseases.

Read the detailed description

The number of people with chronic disease is increasing as is the need of preventive efforts to facilitate their health. Chronic diseases are defined as 'long-term health conditions' that require constant attention and/or limit activities of daily living. People living with one or multiple chronic diseases experience difficulties to live an active everyday life and restrictions of engagement in various activities are common. Interventions that support their process of change and development of self-management in everyday life in relation to their changed capacity needs to be established. Research shows that the access to interventions is facilitated by the use of internet-based solutions. Hence, an internet-based occupational therapy intervention 'Strategies Empowering activities in Everyday life' (SEE) has been developed that will be evaluated in a feasibility trial.

The feasibility study is designed as a longitudinal trial with pre-test, post test evaluation without control group embedded in a mixed method approach. Data will be collected by assessment tools, qualitative interviews and group interviews. Evaluation of the feasibility of the intervention and the study design will be conducted in terms of acceptability, adherence, values, and implementation, from the perspective of patients with chronic disease and health care personnel at different organizational levels in primary care, as well as in out-patient and in-patient care at a regional hospital.

The results from this feasibility study will support the continued development of SEE in future larger-scale evaluation studies. The goal is that SEE will add to existing interventions and becomes implemented in clinical practice. The results will be published in peer-reviewed scientific journals and presented at conferences.

02

Conditions studied

  • Chronic Disease

Browse trials for

Keywords

  • Chronic disease
  • Self-management
  • Activities of daily life
  • Internet-based
  • Tele-rehabilitation
  • E-health
  • Occupational therapy
  • Prevention
  • Rehabilitation
  • Long-term health conditions
03

In context

Chronic Disease

782 studies on the registry are indexed under Chronic Disease; 144 are open to participants now.

This study's planned enrollment of 40 is below the median of 140 across 582 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

Luleå Tekniska Universitet is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with, or at risk of developing, a chronic disease/long-term condition such as long-term pain, stress-related conditions, chronic fatigue syndrome, rheumatological diseases, lung diseases, or neurological conditions.
  • Age: 18-75 years
  • Experiencing difficulties to have an active everyday life and/or experiencing a need to develop self-management strategies in everyday life.
  • Have access to a screen/computer, internet and e-ID as well as being able to use them
  • Be able to participate in the program, including be ready for a process of change
  • Understanding of the Swedish language in written and oral form.

Exclusion criteria

Exclusion Criteria:

  • Sickness or disease which causes difficulties with understanding written and verbal advice (e.g. mental or cognitive illness).
  • Having an ongoing misuse
  • Receiving palliative care
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention

    The group will receive the internet-based intervention 'SEE' focusing on supporting self-management of activities in everyday life to promote health. Beside SEE, they will also receive care as usual.

    Behavioral: Strategies Empowering Activities in Everyday life (SEE 2.0)

Interventions

  • BehavioralStrategies Empowering Activities in Everyday life (SEE 2.0)

    SEEs internet-based intervention process begins with supporting the client to explore the need of and readiness for changes in everyday life. Thereafter, the client is supported to self-analyse their engagement in activities in everyday life along with use of management strategies in everyday life. Next, the client takes on web- modules including short educational movies with subsequent analyses and reflections. The modules aim to support the development of self-management by improving the knowledge of how strategies and changes in daily activities can prevent disabilities and contribute to improved health. After that, the focus is on establishing an activity plan with goals and activity-based management strategies to promote an active everyday life. The clients' implementation of the plan is supported through follow-up meetings. During the whole intervention process, the client is regularly supported by an occupational therapist through feedback and online guiding dialogues.

06

What researchers measure

Primary outcomes

  1. The Satisfaction with Daily Occupation (SDO-13)

    Measures change in satisfaction of daily occupations through a structured interview with 13 questions within areas such as work/studies, leisure, home and self-care occupations. Satisfaction with occupations is measured on an ordinal scale with a score ranging from 0-7. The total rating range between 13-91. Higher score indicates a higher satisfaction with daily occupations.

    Time frame: Change from baseline to four- and twelve months post-base line

  2. Occupational Balance Questionnaire (OBQ)

    Measures change in perceived occupational balance; occupational balance reflects a person's subjective perception of having the right amount of- and the right variation between activities. The OBQ consist of 11 items rated on a four-point ordinal scale, scored 0 to 3. A total score may range between 0 and 33 where a higher score implies a higher sense of occupational balance.

    Time frame: Change from baseline to four- and twelve months post-base line

  3. Occupational values with pre-defined items (Oval-pd).

    Measures change in occupational values which reflects the subjective perception of concrete, symbolic or self-rewarding values in activities. The Oval-pd consists of 18 items rated on a four-point ordinal scale, scored 1 to 4. The responses add up to a total score between 18-72, a higher score indicates higher occupational value in the activities of everyday life.

    Time frame: Change from baseline to four- and twelve months post-base line

Secondary outcomes

  1. Life satisfaction questionnaire (Lisat-11)

    Measures a change in life satisfaction. Lisat-11 consists of 11 items rated on an ordinal scale scored 1-6. A higher score indicates a higher level of life satisfaction.

    Time frame: Change from baseline to four- and twelve months post-base line

  2. Work ability index (WAI)

    Measures a change in self-perceived work ability. Self-perceived work ability is rated on a 10-point ordinal scale and a higher score indicates higher perceived work ability.

    Time frame: Change from baseline to four- and twelve months post-base line

  3. RAND-36

    Measures change in perceived health and function in everyday life and consists of 36 items with an ordinal scale across 8 dimensions of health. The dimensions of health are graded on a scale 0-100 and a higher score indicates a higher perceived health and function in everyday life.

    Time frame: Change from baseline to four- and twelve months post-base line

  4. General Self-Efficacy (GSE-10)

    Measures change in self-reported self-efficacy which consists of 10 items on an ordinal scale from 1-4. The total score ranges from 10-40 and a higher score indicates higher self- efficacy.

    Time frame: Change from baseline to four- and twelve months post-base line

  5. Mental Fatigue Scale (MFS)

    Measures change in perceived mental fatigue and consists of 14 items rated on an ordinal scale (0-3). The summarized score ranges from 0-42. Scores over 10.5 indicate fatigue.

    Time frame: Change from baseline to four- and twelve months post-base line

  6. EuroQol 5 Dimensions (EQ-5D) Thermometer

    Measures a change in perceived health with a score ranging from 0-100. A higher score indicates better perceived health.

    Time frame: Change from baseline to four- and twelve months post-base line

  7. Perceived Stress Scale (PSS)

    Change in perceived stress on 10 items rated on an ordinal scale (0-4). The summarised score range from 0-40. A higher score indicates a higher level of perceived stress.

    Time frame: Change from baseline to four- and twelve months post-base line

Other outcomes

  1. The experience of people with chronic conditions participating in the intervention process of SEE.

    Qualitative individual open-ended interviews with client participants focusing on experiences of SEEs intervention process.

    Time frame: Repeated interviews during the intervention process, one- and four months post-baseline

  2. The acceptability and value of SEE from the perspective of the clients.

    A study specific questionnaire. The items are rated on an ordinal scale, ranging from 1 to 4. Higher scores reflect higher levels of acceptability and value of SEE.

    Time frame: Four months post-baseline

  3. The adherence to SEE.

    The adherence of SEE will be studied with a structured interview using a study specific feasibility registration form assessing whether the intervention is delivered and taken as intended. The structured individual interview based on the feasibility registration form will be conducted with the occupational therapist delivering SEE to each client.

    Time frame: Through intervention completion, an average of 1 year

  4. The experience of how feasibility, implementation, and context influence SEE.

    Experiences the feasibility and the implementation process of SEE from the perspectives of the delivers, i.e., the occupational therapists, their managers and other stakeholders/key persons will be explored qualitatively in groups interviews.

    Time frame: Through study completion, an average of 2 year

  5. Number of participants recruited retention and drop-out rates.

    The recruitment process and resulting sample will be studied by the use of study-specific registration forms.

    Time frame: Through study completion, an average of 2 year

07

Study locations

1 of 2 sites recruiting
08

References and documents

Publications

  • Larsson-Lund M, Karlsson Sundbaum J, Mansson Lexell E, Spinord L. Feasibility study of the internet-based intervention 'Strategies for Empowering activities in Everyday life' (SEE 2.0) for use by people with chronic diseases and long-term disorders in healthcare: a study protocol. BMJ Open. 2025 Oct 21;15(10):e102026. doi: 10.1136/bmjopen-2025-102026. PubMed 41125291 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Jan 2027, 27 months after the start.

Of 319 non-industry interventional studies with no phase under Chronic Disease, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 33. This study's planned 27 months is above that.

Counting every sponsor, half of 329 studies reached it within 21 months; a quarter within 11 and three quarters within 33.

Chronic Disease covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 20, 2024
First posted
Jul 3, 2024
StartActual
Sep 10, 2024
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jun 1, 2027
Last update
Sep 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06484322
Lead sponsor
Luleå Tekniska Universitet
Responsible party
Sponsor
First posted
Jul 3, 2024
Start date
Sep 10, 2024
Primary completion
Jan 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Sep 17, 2025

Study contacts

Maria Larsson-Lund, Professor
Contact
maria.larsson-lund@ltu.se
+0046- 920-493833 ext. +46
Patrik Sjoeberg, Phd student
Contact
patrik.sjoberg@ltu.se
0920-49 21 15 ext. +46
Maria Larsson Lund, Professor
study chair · LTU

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion